Chemoprotection by sulforaphane: Keep one eye beyond Keap1
- 16 April 2005
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 233 (2) , 208-218
- https://doi.org/10.1016/j.canlet.2005.02.033
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Phase II enzyme inducer, sulforaphane, inhibits UVB‐induced AP‐1 activation in human keratinocytes by a novel mechanismMolecular Carcinogenesis, 2004
- A Novel Mechanism of Chemoprotection by SulforaphaneCancer Research, 2004
- Sulforaphane-induced G2/M Phase Cell Cycle Arrest Involves Checkpoint Kinase 2-mediated Phosphorylation of Cell Division Cycle 25CJournal of Biological Chemistry, 2004
- Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cellsCarcinogenesis: Integrative Cancer Research, 2004
- Induction of Phase II Detoxification Enzymes in Rats by Plant-Derived Isothiocyanates: Comparison of Allyl Isothiocyanate with Sulforaphane and Related CompoundsJournal of Agricultural and Food Chemistry, 2004
- Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling PathwayMolecular and Cellular Biology, 2003
- Efficacyof Sulforaphane in EradicatingHelicobacter pyloriin HumanGastric Xenografts Implanted in NudeMiceAntimicrobial Agents and Chemotherapy, 2003
- Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerizationCarcinogenesis: Integrative Cancer Research, 2003
- Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytesCarcinogenesis: Integrative Cancer Research, 2003
- Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in viroAnti-Cancer Drugs, 1998